Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
出版年份 2020 全文链接
标题
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 9, Issue 8, Pages 2480
出版商
MDPI AG
发表日期
2020-08-03
DOI
10.3390/jcm9082480
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe−/− Mice
- (2020) Yang Tang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Senoinflammation: A major mediator underlying age-related metabolic dysregulation
- (2020) Dae Hyun Kim et al. EXPERIMENTAL GERONTOLOGY
- Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
- (2020) Xilan Yang et al. BMC Cardiovascular Disorders
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor
- (2020) Robert Sidlow et al. JAMA Cardiology
- Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure
- (2020) Wesley Tyler Abplanalp et al. JAMA Cardiology
- Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
- (2020) Eleonora Cianflone et al. Cells
- High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential
- (2020) Lambert Busque et al. Blood Advances
- Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice
- (2019) Wei Wang et al. CIRCULATION RESEARCH
- Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
- (2019) Matthias Totzeck et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
- (2019) Farsad Eskandary et al. Trials
- Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer
- (2019) Oscar Calvillo-Argüelles et al. JAMA Cardiology
- Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?
- (2019) Eleonora Cianflone et al. Oxidative Medicine and Cellular Longevity
- CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease
- (2019) Yvonne Döring et al. CIRCULATION
- Inflammation: A Common Contributor to Cancer, Aging, and Cardiovascular Diseases
- (2019) Peter Libby et al. CARDIOVASCULAR RESEARCH
- Aged-senescent cells contribute to impaired heart regeneration
- (2019) Fiona C. Lewis-McDougall et al. AGING CELL
- Estrogen-mediated protection against coronary heart disease: The role of the Notch pathway
- (2019) Francesca Fortini et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cancer and heart disease: associations and relations
- (2019) Rudolf A. Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Notch pathway: a novel therapeutic target for cardiovascular diseases?
- (2019) Giorgio Aquila et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Clonal Hematopoiesis
- (2019) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Notch Signaling Regulates Immune Responses in Atherosclerosis
- (2019) Francesco Vieceli Dalla Sega et al. Frontiers in Immunology
- Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation
- (2019) Silvia Mas-Peiro et al. EUROPEAN HEART JOURNAL
- Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
- (2019) Siddhartha Jaiswal et al. Nature Reviews Cardiology
- Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis
- (2019) Kyoko Ito et al. Cell Reports
- Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
- (2019) Alexander G. Bick et al. CIRCULATION
- Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis
- (2019) Lena Dorsheimer et al. HAEMATOLOGICA
- Clonal hematopoiesis in human aging and disease
- (2019) Siddhartha Jaiswal et al. SCIENCE
- Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
- (2019) Andrew B. Das et al. Blood Cancer Journal
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Lineage restriction analyses in CHIP indicate myeloid bias forTET2and multipotent stem cell origin forDNMT3A
- (2018) Manuel Buscarlet et al. BLOOD
- Somatic Mutations and Clonal Hematopoiesis
- (2018) José J. Fuster et al. CIRCULATION RESEARCH
- CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular DiseaseNovelty and Significance
- (2018) Soichi Sano et al. CIRCULATION RESEARCH
- New Insights from Studies of Clonal Hematopoiesis
- (2018) Christopher J. Gibson et al. CLINICAL CANCER RESEARCH
- An inflammatory environment containing TNFα favors Tet2 -mutant clonal hematopoiesis
- (2018) Samuel O. Abegunde et al. EXPERIMENTAL HEMATOLOGY
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
- (2018) Soichi Sano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
- (2018) Christopher Maximilian Arends et al. LEUKEMIA
- The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
- (2018) Huihui Zhao et al. LEUKEMIA RESEARCH
- Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
- (2018) Ofir Wolach et al. Science Translational Medicine
- Aging-Induced Biological Changes and Cardiovascular Diseases
- (2018) James Oluwagbamigbe Fajemiroye et al. Biomed Research International
- JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
- (2018) Bärbel Edelmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
- (2018) Di Wu et al. NATURE
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis
- (2018) Zhigang Cai et al. Cell Stem Cell
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
- (2018) Lena Dorsheimer et al. JAMA Cardiology
- CHIPping Away at the Pathogenesis of Heart Failure
- (2018) Peter Libby et al. JAMA Cardiology
- Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases
- (2017) Daniela Galli et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
- (2017) Feng Pan et al. Nature Communications
- In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases
- (2016) Luca Biasco et al. Cell Stem Cell
- Shared Risk Factors in Cardiovascular Disease and Cancer
- (2016) Ryan J. Koene et al. CIRCULATION
- Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes
- (2016) Carlo Finelli et al. CURRENT PHARMACEUTICAL DESIGN
- Clonal Hematopoiesis of Indeterminate Potential
- (2016) Michael Heuser et al. Deutsches Arzteblatt International
- Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
- (2016) Aarat Patel et al. Drug Design Development and Therapy
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- Aging, clonal hematopoiesis and preleukemia: not just bad luck?
- (2015) Liran I. Shlush et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality
- (2015) Emily Jane Gallagher et al. PHYSIOLOGICAL REVIEWS
- Overlapping Requirements for Tet2 and Tet3 in Normal Development and Hematopoietic Stem Cell Emergence
- (2015) Cheng Li et al. Cell Reports
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
- (2014) S. Leah Etheridge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia
- (2013) C. M. Hobbs et al. BLOOD
- Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations
- (2013) Daichi Inoue et al. JOURNAL OF CLINICAL INVESTIGATION
- Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
- (2012) V. Rosti et al. BLOOD
- The Intersection Between Aging and Cardiovascular Disease
- (2012) Brian J. North et al. CIRCULATION RESEARCH
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
- (2012) Véronique Gelsi-Boyer et al. Journal of Hematology & Oncology
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms
- (2011) L. Teofili et al. BLOOD
- The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels
- (2011) Nehal N. Mehta et al. EUROPEAN HEART JOURNAL
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
- (2011) Heribert Schunkert et al. NATURE GENETICS
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
- (2009) S. Sozer et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS
- (2009) M. Y. Follo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
- (2008) Elizabeth A. Griffiths et al. SEMINARS IN HEMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started